Biomarin Pharmaceutical Inc
XMUN:BM8
Biomarin Pharmaceutical Inc
XMUN:BM8
Price:
46.355
EUR
Market Closed
Market Cap:
€8.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Biomarin Pharmaceutical Inc
XMUN:BM8
|
US |
|
N
|
Netflix Inc
BMV:NFLX
|
US |
|
S
|
SAP SE
XHAM:SAP
|
DE |
|
Kumba Iron Ore Ltd
OTC:KUMBF
|
ZA |
|
T
|
Toronto-Dominion Bank
LSE:0VL8
|
CA |
|
Samsung Electronics Co Ltd
LSE:BC94
|
KR |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
DE |
|
P
|
Panasonic Holdings Corp
XMUN:MAT1
|
JP |
|
Arverne Group SA
PAR:ARVEN
|
FR |
|
A
|
AXA SA
F:AXAA
|
FR |
|
Pennon Group PLC
F:3PN0
|
UK |
Multiples-Based Value
The Multiples-Based Value for 
Biomarin Pharmaceutical Inc (BM8) under the Base Case is hidden
EUR.
Compared with the current market price of 46.355 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BM8 Multiples-Based Value
LOCKED
